ctrl K

TriSalus Life Sciences In... (TLSI)

NASDAQ: TLSI · Real-Time Price · USD

5.16

0.03 (0.58%)

At close: May 01, 2025, 3:59 PM

5.09

-1.36%

After-hours: May 01, 2025, 04:05 PM EDT

TriSalus Life Sciences Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	29.43M	18.51M	12.4M	8.4M	5.43M
Cost of Revenue	4.1M	2.6M	2.26M	1.19M	2.2M
Gross Profit	25.33M	15.91M	10.14M	7.21M	3.24M
Operating Income	-36.16M	-54.15M	-36.44M	-24.03M	-25.65M
Interest Income	404K	431K	180K	64K	n/a
Pretax Income	-30.04M	-59.03M	-47.18M	-28.84M	-31.83M
Net Income	-33.23M	-59.04M	-47.19M	-28.84M	-31.83M
Selling & General & Admin	43.8M	40.55M	25.22M	17.02M	13.06M
Research & Development	17.69M	29.51M	21.36M	14.22M	15.82M
Other Expenses	n/a	n/a	-8.73M	746K	n/a
Operating Expenses	61.49M	70.06M	46.58M	31.24M	29.02M
Interest Expense	3.09M	16K	1K	1.76M	n/a
Selling & Marketing Expenses	25.84M	17.03M	12.74M	8.26M	6.19M
Cost & Expenses	65.6M	72.66M	48.84M	32.43M	31.22M
Income Tax Expense	6K	9K	9K	3K	4K
Shares Outstanding (Basic)	26.5M	26.47M	29.61M	31.25M	30.56M
Shares Outstanding (Diluted)	26.5M	26.47M	29.61M	31.25M	30.56M
EPS (Basic)	-1.25	-2.23	-1.59	-0.92	-1.04
EPS (Diluted)	-1.25	-2.23	-1.59	-0.92	-1.04
EBITDA	-36.16M	-58.3M	-46.76M	-23.57M	-25.32M
EBIT	-33.13M	-59.01M	-47.18M	-27.08M	-711.39K
Depreciation & Amortization	-3.04M	702K	414K	464K	321K